Disseminated Mycobacterium genavense infection in a patient with a novel partial interleukin-12/23 receptor β1 deficiency

Clinical Immunology

Volumn 144, Issue 2, 2012, Pages 83-86

  Potjewijd, Judith ^a,d   de Paus, Roelof A ^b   van Wengen, Annelies ^b   Damoiseaux, Jan ^a   Verbon, Annelies ^c   de Vosse, Esther van ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Interleukin 12 23 receptor 1 deficiency; Nontuberculous mycobacteria; Type 1 cytokine pathway

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 23 RECEPTOR; RIFAMPICIN;

ADULT; AMINO ACID SUBSTITUTION; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; GENE MUTATION; HUMAN; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM GENAVENSE INFECTION; NIGHT SWEAT; ONSET AGE; PRIORITY JOURNAL; RETROPERITONEAL DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION;

ADULT; BASE SEQUENCE; CYTOKINES; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-12 RECEPTOR BETA 1 SUBUNIT; MALE; MUTATION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN; STAT4 TRANSCRIPTION FACTOR;

EID: 84861965202     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.05.007     Document Type: Article

References (8)

1. Euzéby J.P. List of prokaryotic names with standing in nomenclature-genus Mycobacterium Available at:. http://www.bacterio.cict.fr/m/mycobacterium.html.
2. Jarzembowski J.A., Young M.B. Nontuberculous mycobacterial infections. Arch. Pathol. Lab. Med. 2008, 132:1333-1341.
3. Salvana E.M.T., Cooper G.S., Salata R.A. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J. Infect. 2007, 55:484-487.
4. van de Vosse E., Hoeve M.A., Ottenhoff T.H.M. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 2004, 4:739-749.
5. van de Vosse E., Ottenhoff T.H.M. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect. 2006, 4:1167-1173.
6. de Beaucoudrey L., Samarina A., Bustamante J., Cobat A., Boisson-Dupuis S., Feinberg J., et al. Revisiting human IL-12Rβ1 deficiency: a survey from 141 patients from 30 countries. Medicine 2010, 89:381-402.
7. van de Vosse E., de Paus R.A., van Dissel J.T., Ottenhoff T.H.M. Molecular complementation of IL-12Rβ1 deficiency reveals functional differences between IL-12Rβ1 alleles including partial IL-12Rβ1 deficiency. Hum. Mol. Genet. 2005, 14:3847-3855.
8. Lichtenauer-Kaligis E.G.R., de Boer T., Verreck F.A.W., van Voorden S., Hoeve M.A., van de Vosse E., et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor β1 deficient patients and evidence for the existence of partial IL-12 receptor β1 deficiency. Eur. J. Immunol. 2003, 33:59-69.